Effect of Empagliflozin on Epicardial Adipose Tissue Volume in Patients with Type 2 Diabetes, or Rrediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF) (original) (raw)
Turgut, C. et al. (2024) Effect of Empagliflozin on Epicardial Adipose Tissue Volume in Patients with Type 2 Diabetes, or Rrediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF). ESC Congress 2024, London, UK, 30 Aug-02 Sept 2024.(doi: 10.1093/eurheartj/ehae666.1018)
Full text not currently available from Enlighten.
Abstract
No abstract available.
| Item Type: | Conference or Workshop Item |
|---|---|
| Additional Information: | Abstract published in European Heart Journal, Volume 45, Issue Supplement_1. DOI: 10.1093/eurheartj/ehae666.1018. This trial was supported by an investigator-initiated study grant from Boehringer Ingelheim. |
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Lee, Dr Matthew and Mark, Professor Patrick and Jhund, Professor Pardeep and Petrie, Professor Mark and Sattar, Professor Naveed and McMurray, Professor John |
| Authors: | Turgut, C., Fernando, J., Berry, C., Campbell, R.T., Docherty, K.F., Dreisbach, J.G., Jhund, P.S., Mangion, K., Mark, P.B., McMurray, J.J.V., Osmanska, J., Roditi, G., Petrie, M.C., Sattar, N., and Lee, M. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
| Published Online: | 28 October 2024 |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
| ID Code: | 340847 |
|---|---|
| Depositing User: | Publications Router |
| Datestamp: | 16 Jan 2025 14:28 |
| Last Modified: | 17 Jan 2025 02:32 |
| Date of first online publication: | 28 October 2024 |